CR9523A - Tableta recubierta de azucar - Google Patents
Tableta recubierta de azucarInfo
- Publication number
- CR9523A CR9523A CR9523A CR9523A CR9523A CR 9523 A CR9523 A CR 9523A CR 9523 A CR9523 A CR 9523A CR 9523 A CR9523 A CR 9523A CR 9523 A CR9523 A CR 9523A
- Authority
- CR
- Costa Rica
- Prior art keywords
- sugar
- covered tablet
- oxygen
- active ingredient
- tablet
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
- A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/4035—Isoindoles, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Abstract
Se describe una preparacion en donde un ingrediente activo inestable al oxigeno es estabilizado por un recubrimiento de una porcion que contiene el ingrediente activo inestable al oxigeno con una capa de recubrimiento con azucar que contiene alcohol de azucar como material base de recubrimiento con azucar y un aglutinante.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005171443 | 2005-06-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
CR9523A true CR9523A (es) | 2008-02-04 |
Family
ID=37498554
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR9523A CR9523A (es) | 2005-06-10 | 2007-11-15 | Tableta recubierta de azucar |
Country Status (19)
Country | Link |
---|---|
US (1) | US20090030064A1 (es) |
EP (1) | EP1889611A1 (es) |
JP (1) | JPWO2006132360A1 (es) |
KR (1) | KR20080014014A (es) |
CN (1) | CN101193625A (es) |
AR (1) | AR054133A1 (es) |
AU (1) | AU2006256038A1 (es) |
BR (1) | BRPI0611058A2 (es) |
CA (1) | CA2610342A1 (es) |
CR (1) | CR9523A (es) |
IL (1) | IL187407A0 (es) |
MA (1) | MA29540B1 (es) |
NO (1) | NO20080175L (es) |
NZ (1) | NZ563820A (es) |
PE (1) | PE20070077A1 (es) |
RU (1) | RU2407515C2 (es) |
TW (1) | TW200716207A (es) |
WO (1) | WO2006132360A1 (es) |
ZA (1) | ZA200710333B (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101945657B (zh) | 2008-02-11 | 2015-04-22 | 大日本住友制药株式会社 | 具有改善的溶出性的片剂 |
TW201021832A (en) * | 2008-09-30 | 2010-06-16 | Astellas Pharma Inc | Pharmaceutical composition for oral administration |
EP2474582B1 (en) * | 2009-09-02 | 2017-11-22 | Nippon Soda Co., Ltd. | Coating agent comprising hydroxyalkyl cellulose |
CN101804042A (zh) * | 2010-04-16 | 2010-08-18 | 山东新华制药股份有限公司 | 普拉格雷片剂的制备方法 |
WO2014203029A1 (en) * | 2013-06-17 | 2014-12-24 | Freescale Semiconductor, Inc. | Efficient scheduling in asynchronous contention-based system |
FR3013186B1 (fr) * | 2013-11-19 | 2019-07-19 | Roquette Freres | Nouveaux snacks non allergenes contenant des proteines vegetales |
CN103977427A (zh) * | 2014-05-08 | 2014-08-13 | 王�琦 | 一种糖衣产气粉配方及其制备方法 |
FR3067567B1 (fr) * | 2017-06-19 | 2019-07-05 | Roquette Freres | Nouveau procede de drageification et formes solides drageifiees presentant des formes irregulieres |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4423086A (en) * | 1979-10-17 | 1983-12-27 | Roquette Freres | Process for hard coating with sorbitol and products obtained thereby |
JPH0816052B2 (ja) * | 1988-11-21 | 1996-02-21 | エスエス製薬株式会社 | 糖衣錠 |
JP3507211B2 (ja) * | 1995-07-13 | 2004-03-15 | 三菱化学株式会社 | 糖衣液及び糖衣錠 |
CN1297550C (zh) * | 1998-12-04 | 2007-01-31 | 武田药品工业株式会社 | 苯并呋喃衍生物及其制备和用途 |
JP2001139495A (ja) * | 1999-11-19 | 2001-05-22 | Shin Etsu Chem Co Ltd | フィルムコーティング剤及び経口固形製剤 |
AT500063A1 (de) * | 1999-11-23 | 2005-10-15 | Sandoz Ag | Beschichtete tablettenkerne |
JP2002047174A (ja) * | 2000-05-26 | 2002-02-12 | Towa Chem Ind Co Ltd | 無糖コーティング製剤及びその製造方法 |
JP2002179559A (ja) * | 2000-10-06 | 2002-06-26 | Takeda Chem Ind Ltd | 薄層糖衣錠およびその製造方法 |
JP2003113060A (ja) * | 2001-10-02 | 2003-04-18 | Lion Corp | 発泡成分含有糖衣物 |
JP4336074B2 (ja) * | 2001-11-15 | 2009-09-30 | 三菱商事フードテック株式会社 | 色調および食感が良好な硬質糖衣錠剤 |
WO2003051355A1 (fr) * | 2001-12-19 | 2003-06-26 | Takeda Chemical Industries, Ltd. | Compositions solides refermant des composes instables a l'oxygene et procede de stabilisation de ces composes |
JP4590034B2 (ja) * | 2002-01-31 | 2010-12-01 | 三菱商事フードテック株式会社 | 硬質糖衣製剤、糖衣液及び硬質糖衣製剤の製造方法 |
JP2004123578A (ja) * | 2002-09-30 | 2004-04-22 | Dainippon Ink & Chem Inc | 糖衣錠およびその製造方法 |
JP2005298373A (ja) * | 2004-04-08 | 2005-10-27 | Kyowa Hakko Kogyo Co Ltd | 吸水性アミノ酸含有糖衣錠剤 |
JP4984455B2 (ja) * | 2004-08-18 | 2012-07-25 | 日本新薬株式会社 | 二重被覆錠剤 |
-
2006
- 2006-06-07 PE PE2006000633A patent/PE20070077A1/es not_active Application Discontinuation
- 2006-06-08 TW TW095120313A patent/TW200716207A/zh unknown
- 2006-06-09 KR KR1020077028672A patent/KR20080014014A/ko not_active Application Discontinuation
- 2006-06-09 US US11/921,731 patent/US20090030064A1/en not_active Abandoned
- 2006-06-09 BR BRPI0611058-4A patent/BRPI0611058A2/pt not_active IP Right Cessation
- 2006-06-09 WO PCT/JP2006/311618 patent/WO2006132360A1/ja active Application Filing
- 2006-06-09 JP JP2007520182A patent/JPWO2006132360A1/ja not_active Withdrawn
- 2006-06-09 RU RU2007145426/15A patent/RU2407515C2/ru not_active IP Right Cessation
- 2006-06-09 CA CA002610342A patent/CA2610342A1/en not_active Abandoned
- 2006-06-09 AU AU2006256038A patent/AU2006256038A1/en not_active Abandoned
- 2006-06-09 EP EP06766530A patent/EP1889611A1/en not_active Withdrawn
- 2006-06-09 NZ NZ563820A patent/NZ563820A/en not_active IP Right Cessation
- 2006-06-09 CN CNA2006800206046A patent/CN101193625A/zh active Pending
- 2006-06-09 ZA ZA200710333A patent/ZA200710333B/xx unknown
- 2006-06-09 AR ARP060102421A patent/AR054133A1/es not_active Application Discontinuation
-
2007
- 2007-11-15 CR CR9523A patent/CR9523A/es not_active Application Discontinuation
- 2007-11-15 IL IL187407A patent/IL187407A0/en unknown
- 2007-12-10 MA MA30465A patent/MA29540B1/fr unknown
-
2008
- 2008-01-10 NO NO20080175A patent/NO20080175L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ZA200710333B (en) | 2009-03-25 |
NZ563820A (en) | 2010-03-26 |
NO20080175L (no) | 2008-03-04 |
CA2610342A1 (en) | 2006-12-14 |
RU2407515C2 (ru) | 2010-12-27 |
IL187407A0 (en) | 2008-02-09 |
US20090030064A1 (en) | 2009-01-29 |
CN101193625A (zh) | 2008-06-04 |
RU2007145426A (ru) | 2009-06-20 |
JPWO2006132360A1 (ja) | 2009-01-08 |
AR054133A1 (es) | 2007-06-06 |
TW200716207A (en) | 2007-05-01 |
PE20070077A1 (es) | 2007-02-07 |
WO2006132360A1 (ja) | 2006-12-14 |
EP1889611A1 (en) | 2008-02-20 |
MA29540B1 (fr) | 2008-06-02 |
AU2006256038A1 (en) | 2006-12-14 |
BRPI0611058A2 (pt) | 2011-02-22 |
KR20080014014A (ko) | 2008-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR9523A (es) | Tableta recubierta de azucar | |
AR068369A1 (es) | Sal de xinafoato de n4-[(2,2-difluor-4h-benzo[1,4]oxazin-3-on)-6-il]-5-fluor-n2-[3-(metilaminocarbonilmetilenoxi)-fenil]2,4-pirimidindiamina" | |
AR068114A1 (es) | Disposicion electroluminiscente | |
AR051128A1 (es) | Composiciones encapsuladas para activos, termicamente estables, altamente resistentes | |
BRPI0814593A2 (pt) | Composto, composição farmacêutica que o contém e uso do composto. | |
CL2011000935A1 (es) | Composicion farmaceutica que comprende acetaminofeno y un material de tramadol complejo, que exhibe una liberacion sostenida y coordinada a traves de una capa de liberacion sostenida y otra de liberacion inmediata; metodo de preparacion;y el uso de un material complejo de tramadol y acetaminofeno para preparar un medicamento para el tratamiento del dolor. | |
BRPI0716171A2 (pt) | composto, composiÇço farmacÊutica e uso de um composto. | |
CL2007002218A1 (es) | Uso de 3-(4-amino-1-oxo-1,3-dihidro-isoindol-2-il)-piperidina 2,6-diona para la preparacion de un medicamento util para el tratamiento de linfoma de celula de capa. | |
BRPI0606339A2 (pt) | formas farmacêuticas resistentes a álcool | |
CR8845S (es) | Recipiente cubierto | |
DK1876897T3 (da) | Aktivstofkombinationer | |
EP2078731A4 (en) | PHARMACEUTICAL COMPOSITION COMPRISING ANTI-HB-EGF ANTIBODY AS ACTIVE INGREDIENT | |
ES2513691T3 (es) | Preparación transdérmica | |
CR8683S (es) | Recipiente cubierto para comida | |
BRPI0908208A2 (pt) | Composto derivado de oxazolidinona, medicamento, composição farmacêutica que o contém e uso desse composto. | |
CL2009000004A1 (es) | Forma cristalina de r-2-(4-ciclopropansulfonil-fenil)-n-pirazin-2-il-3-(tetrahidropiran-4-il)-propionamida; composicion farmaceutica que comprende a dicha forma cristalina; y uso para el tratamiento de diabetes o hiperglicemia. | |
BRPI0816678A2 (pt) | Composição que contém p-metano-3,8-diol e seu uso como repelente de insetos. | |
BRPI0907892A2 (pt) | Composto antibiótico azatricíclico, medicamento, composição farmacêutica que o contém e uso do mesmo | |
CL2008002130A1 (es) | Compuestos derivados de 2-amino-cromen-4-ona; composicion farmaceutica que lo comprende; y uso en el tratamiento de una enfermedad que es aliviada por la inhibicion de la proteina quinasa dependiente de adn (adn-pk), tal como cancer. | |
EA201200484A1 (ru) | Фармацевтическая композиция с действующими веществами - метформином и ситаглиптином или вилдаглиптином | |
UY28987A1 (es) | Cuerpos de moldeo solidos que contienen sustancia activa para el uso externo frente a parasitos en animales | |
BRPI0810399A2 (pt) | Composto, composição farmacêutica que o contém e uso do mesmo | |
BRPI0717369A2 (pt) | Composto, medicamento, composição farmacêutica que o contém e uso do composto. | |
CR9852S (es) | Cubierta de receptaculo y taza de medir combinadas | |
BRPI0911772A2 (pt) | composto, composição farmacêutica, e, uso do composto. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal (granting procedure) |